PDSB vs. MSFRX
Compare and contrast key facts about PDS Biotechnology Corporation (PDSB) and MFS Total Return Fund (MSFRX).
MSFRX is managed by MFS. It was launched on Oct 5, 1970.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PDSB or MSFRX.
Performance
PDSB vs. MSFRX - Performance Comparison
Returns By Period
In the year-to-date period, PDSB achieves a -55.73% return, which is significantly lower than MSFRX's 11.39% return.
PDSB
-55.73%
-32.52%
-29.49%
-64.29%
0.75%
N/A
MSFRX
11.39%
1.26%
7.84%
13.53%
3.03%
3.49%
Key characteristics
| PDSB | MSFRX | |
|---|---|---|
| Sharpe Ratio | -0.84 | 1.77 |
| Sortino Ratio | -1.31 | 2.38 |
| Omega Ratio | 0.85 | 1.34 |
| Calmar Ratio | -0.65 | 0.93 |
| Martin Ratio | -1.50 | 7.11 |
| Ulcer Index | 43.23% | 1.94% |
| Daily Std Dev | 77.35% | 7.76% |
| Max Drawdown | -99.86% | -36.74% |
| Current Drawdown | -99.53% | -3.35% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between PDSB and MSFRX is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
PDSB vs. MSFRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PDS Biotechnology Corporation (PDSB) and MFS Total Return Fund (MSFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PDSB vs. MSFRX - Dividend Comparison
PDSB has not paid dividends to shareholders, while MSFRX's dividend yield for the trailing twelve months is around 2.22%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PDSB PDS Biotechnology Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MSFRX MFS Total Return Fund | 2.22% | 2.37% | 1.88% | 1.40% | 1.82% | 1.91% | 2.25% | 1.93% | 2.17% | 2.77% | 4.58% | 2.85% |
Drawdowns
PDSB vs. MSFRX - Drawdown Comparison
The maximum PDSB drawdown since its inception was -99.86%, which is greater than MSFRX's maximum drawdown of -36.74%. Use the drawdown chart below to compare losses from any high point for PDSB and MSFRX. For additional features, visit the drawdowns tool.
Volatility
PDSB vs. MSFRX - Volatility Comparison
PDS Biotechnology Corporation (PDSB) has a higher volatility of 28.33% compared to MFS Total Return Fund (MSFRX) at 2.06%. This indicates that PDSB's price experiences larger fluctuations and is considered to be riskier than MSFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.